Ocugen (OCGN) Gains from Investment Securities (2014 - 2025)
Ocugen posted quarterly Gains from Investment Securities of -$8000.0 for Q4 2025, up 11.11% year-on-year from -$7200.0 in Q4 2024, and down 100.6% on a QoQ basis from $1.3 million in Q3 2025.
Ocugen (OCGN) has 12 years of Gains from Investment Securities data on file, last reported at -$8000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities rose 11.11% year-over-year to -$8000.0; the trailing twelve-month figure through Mar 2026 stood at $880000.0 (up 120.0% YoY), and the FY2025 full-year result was $1.3 million, up 3635.14% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$8000.0, down from $1.3 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.3 million in Q3 2025 and bottomed at -$448000.0 in Q2 2025.
- The 5-year median for Gains from Investment Securities is -$7000.0 (2021), against an average of $157750.0.
- Peak annual rise in Gains from Investment Securities reached 14944.44% in 2025, while the deepest fall reached 4380.0% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $10000.0 in 2021, then surged by 6610.0% to $671000.0 in 2022, then dropped by 14.75% to $572000.0 in 2023, then plunged by 101.57% to -$9000.0 in 2024, then gained by 11.11% to -$8000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$8000.0 (Q4 2025), $1.3 million (Q3 2025), and -$448000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | -448,000.00 |
| Jun 30, 2025 | -448,000.00 |
| Mar 31, 2025 | 428,000.00 |
| Mar 31, 2025 | 428,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Dec 31, 2023 | 572,000.00 |
| Dec 31, 2023 | 572,000.00 |
| Sep 30, 2023 | 363,000.00 |
| Sep 30, 2023 | 363,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Mar 31, 2023 | -352,000.00 |
| Mar 31, 2023 | -352,000.00 |
| Dec 31, 2022 | 671,000.00 |
| Dec 31, 2022 | 671,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | -6,000.00 |
| Jun 30, 2021 | -6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Dec 31, 2020 | 331,000.00 |
| Dec 31, 2020 | 331,000.00 |
| Sep 30, 2020 | 6,000.00 |
| Sep 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Mar 31, 2020 | 6,000.00 |
| Mar 31, 2020 | 6,000.00 |
| Dec 31, 2019 | -5,000.00 |
| Dec 31, 2019 | -5,000.00 |
| Sep 30, 2019 | -1,021.00 |
| Sep 30, 2019 | -1,021.00 |
| Jun 30, 2019 | 5,000.00 |
| Jun 30, 2019 | 5,000.00 |
| Mar 31, 2019 | 5,964.00 |
| Mar 31, 2019 | 5,964.00 |
| Dec 31, 2018 | -51,889.00 |
| Dec 31, 2018 | -51,889.00 |
| Sep 30, 2018 | 1.53 Mn |
| Sep 30, 2018 | 1.53 Mn |
| Jun 30, 2018 | -3.50 Mn |
| Jun 30, 2018 | -3.50 Mn |
| Mar 31, 2018 | 1,236.00 |
| Mar 31, 2018 | 1,236.00 |
| Dec 31, 2017 | 809,000.00 |
| Dec 31, 2017 | 809,000.00 |
| Sep 30, 2017 | 269,000.00 |
| Sep 30, 2017 | 269,000.00 |
| Jun 30, 2017 | 135,000.00 |
| Jun 30, 2017 | 135,000.00 |
| Mar 31, 2017 | 486,450.00 |
| Mar 31, 2017 | 486,450.00 |
| Dec 31, 2016 | 1.58 Mn |
| Dec 31, 2016 | 1.58 Mn |
| Sep 30, 2016 | 3.06 Mn |
| Sep 30, 2016 | 3.06 Mn |
| Jun 30, 2016 | 1.34 Mn |
| Jun 30, 2016 | 1.34 Mn |
| Mar 31, 2016 | 194,040.00 |
| Mar 31, 2016 | 194,040.00 |
| Dec 31, 2015 | 285,000.00 |
| Dec 31, 2015 | 285,000.00 |
| Sep 30, 2015 | 1.23 Mn |
| Sep 30, 2015 | 1.23 Mn |
| Jun 30, 2015 | 111,303.00 |
| Jun 30, 2015 | 111,303.00 |
| Mar 31, 2015 | 92,734.00 |
| Mar 31, 2015 | 92,734.00 |
| Dec 31, 2014 | -77,000.00 |
| Dec 31, 2014 | -77,000.00 |
| Sep 30, 2014 | -58,000.00 |
| Sep 30, 2014 | -58,000.00 |